Company: SXTPW
Filing Date: 2025-07-16
Form Type: 424B4
Source: 0001213900-25-064472
Chunk: 52

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-16
Form: 424B4
Chunk 52
---
 Accumulated other comprehensive income                                                                                                                                                                    |     | $      |     125,567 |   |     | $           |     125,567 |   |
| Accumulated deficit                                                                                                                                                                                       |     | $      | (42,404,506 | ) |     | $           | (42,404,506 | ) |
| Total stockholders’ equity                                                                                                                                                                                |     | $      |   4,028,889 |   |     | $           |   8,209,400 |   |
| Total capitalization                                                                                                                                                                                      |     | $      |   4,175,391 |   |     | $           |   8,355,902 |   |

| (1) | The foregoing discussion and                                                                               
 tables above are based on 1,472,891 shares of common stock outstanding as of March 31, 2025, and excludes: |

| ● | 57,068 shares of common stock                     
 reserved for future issuance under the 2022 Plan; |

| ● | 2,127,070 shares of common                                                                                     
 stock issuable upon exercise of outstanding warrants at a weighted average exercise price of $15.85 per share; |

| ● | 137,637 shares of common stock                                                                              
 issuable upon exercise of outstanding options at a weighted average exercise price of $13.92 per share; and |

| ● | shares of common stock issuable                                   
 upon the conversion of 76,480 shares of Series A Preferred Stock. |

<div align='center'>26

DESCRIPTION OF Capital Stock</div>

The following description of our capital stock is only a summary and is qualified in its entirety by reference to the actual terms and provisions of the capital stock contained in our Certificate of Incorporation and our Bylaws, copies of which are attached as exhibits to the registration statement of which this prospectus forms a part.

General

We are authorized to issue one class of stock.
The total number of shares of stock which we are authorized to issue is 151,000,000 shares of capital stock, 150,000,000 of which are
common stock, $0.0001 par value per share, and 1,000,000 of which are “blank check” Series A Preferred Stock. As of July 15,
2025, 1,472,891 shares of common stock were issued and outstanding and held by 21 stockholders of record.

Common Stock

The holders of our common stock are entitled to
the following